Taxotere Chemotherapy Drug Investigation – Women Left With Permanent Hair Loss

Tittle & Perlmuter is investigating Taxotere litigation claims all Across Ohio, including the greater Cleveland area

Temporary hair loss is a well-known side effect of chemotherapy treatment. However, thousands of women who were treated with Taxotere, a chemotherapy drug commonly prescribed to treat breast cancer, have been left with permanent hair loss, even years after finishing treatment. These brave cancer survivors are constantly reminded of their battle with cancer every time they look in the mirror, which can be devastating emotionally.

Drug Manufacturer Scandal

What’s worse is the lawsuits that have been filed allege that the drug manufacturer, Sanofi-Aventis, knew of the side effects of Taxotere and did not warn patients, engaging in illegal marketing practices to boost sales. The lawsuits claim that Sanofi-Aventis went as far as to conceal this information from the public and even pay off some health care providers to prescribe the drug. If these allegations are true, then Sanofi-Aventis’ focus was on their bottom line, not on the well-being of the patients depending on Taxotere to beat cancer. Thousands of women were not informed of the side effects and have been left hairless or with thin patches of hair.

Tittle & Perlmuter – Cleveland Attorneys Investigating Taxotere

Tittle & Perlmuter is committed to investigating these Taxotere claims and getting justice for individuals who have been harmed by the drug. We are currently investigating claims for individuals who have/had Stage 1 or Stage 2 cancer.

If you have questions about the Taxotere litigation or if you or a loved one has experienced severe side effects after taking Taxotere, please contact us. For more information about Tittle & Perlmuter please visit our website.